N

Nivagen Pharmaceuticals

Develops, acquires, and markets generic drugs

QA/QMS Senior Specialist - Deviations & Investigations

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSacramento, CA, USAIn-person

About the Job

Requirements

  • A bachelor's degree in Life Sciences, Chemistry, Pharmacy, Microbiology, Engineering, or a related field is required.
  • A minimum of 7-10 years of experience in quality assurance, conducting deviation investigations in sterile pharmaceutical manufacturing is required.
  • Demonstrated expertise in root cause analysis tools, including Ishikawa, 5-Why, FMEA, and fault tree analysis is required.
  • Hands-on experience investigating sterile-specific deviations, including media fill failures, environmental monitoring excursions, filter integrity test failures, particulate contamination, and aseptic processing breaches is required.
  • Proficiency with TrackWise, Veeva QMS, or equivalent electronic quality management systems is required.
  • Strong technical writing skills and the ability to author clear, concise, and FDA-defensible investigation reports are required.
  • Working knowledge of 21 CFR Parts 210, 211, and 212; ICH Q7 and Q10; and FDA guidance on investigating deviations is required.
  • Willingness to cross-train across CAPA and Change Control subsystems is required.

Responsibilities

  • Own the deviation lifecycle from initiation through investigation, root cause analysis, corrective action identification, and closure within established timelines.
  • Serve as the primary point of contact for deviation-related activities across Manufacturing, Quality Control, Engineering, and Validation departments.
  • Conduct root cause analyses using structured methodologies, including Ishikawa (6M), 5-Why, and fault tree analysis.
  • Author investigation narratives, initial quality assessments (IQAs), and final deviation reports in TrackWise.
  • Classify deviations by severity (Critical, Major, Minor) and assess impact on product quality, patient safety, validated state, and regulatory compliance.
  • Coordinate batch disposition activities with QA batch release and QC laboratory teams.
  • Identify recurring deviation trends and escalate systematic issues to the CAPA system.
  • Track and report deviation KPIs, including open aging, cycle time, recurrence rates, and root cause categories, during management review.
  • Support internal audits and FDA/regulatory inspections by providing deviation records, trending data, and investigation summaries.
  • Ensure deviations comply with ALCOA+ data integrity principles and 21 CFR Part 11 requirements for electronic records.
  • Serve as a trained backup for related QMS subsystems (CAPA and Change Control), providing cross-functional coverage during peak workload periods, absences, or as needed to ensure continuity of quality operations.

Desired Qualifications

  • Experience supporting FDA Pre-Approval Inspections (PAI) or routine GMP inspections is a plus.
  • Working familiarity with adjacent QMS processes (CAPA and Change Control) is strongly preferred.

About the Company

Nivagen Pharmaceuticals

Develops, acquires, and markets generic drugs

Nivagen Pharmaceuticals develops, acquires, and sells generic prescription drugs and OTC products for the North American market. It leverages global partnerships with FDA-approved manufacturing facilities to deliver high-quality, affordable products and collaborates with the world’s best CROs and CRAMs to develop and manufacture niche generics. The company supports small FDA-qualified manufacturers entering the U.S. market and differentiates itself through its ability to launch new generic products and its strong sales and marketing team, rather than relying on a single manufacturing or development approach. Revenue comes from product development, co-development, acquisitions, in-licensing, and providing sales and marketing services. Nivagen aims to grow its portfolio by forging CRO/CRAM partnerships, acquiring existing products, and expanding its product lineup to capture a larger share of the evolving generic and OTC market in North America.

Company size
51-200
Company stage
Growth Equity (Venture Capital)
Total funding
$26M
Headquarters
Rancho Cordova, CA
Founded
2009

Recently Posted Jobs

Explore more opportunities at Nivagen Pharmaceuticals

See more jobs